+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 80Years
All Genders
ID06351475

Comparing 20% Albumin Plus Ringer Lactate Versus Ringer Lactate Alone for Fluid Therapy During Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy

Led by Assistance Publique - Hôpitaux de Paris · Updated on 2026-09-29

140

Participants Needed

8

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of 20% albumin combined with Ringer Lactate versus Ringer Lactate alone for fluid therapy during cytoreductive surgery CRS with hyperthermic intraperitoneal chemotherapy HIPEC. This surgery involves large fluid shifts due to resection and inflammation, and fluid management may affect postoperative outcomes. The study aims to assess whether using albumin reduces the volume of crystalloid fluids needed and improves patients prognosis after surgery. Participants will be randomly assigned to one of two groups. The intervention group receives a bolus of 20% albumin during anesthesia induction, followed by albumin infusion adjusted to vascular filling volume, combined with Ringer Lactate. The control group receives Ringer Lactate alone based on current guidelines. Albumin infusion is stopped at surgery end. This is an open-label, randomized, parallel-group multicenter trial. Participants are followed up to 28 days after surgery. Researchers will evaluate postoperative complications using the Comprehensive Complication Index at day 28 as the primary outcome. Secondary outcomes include mortality, fluid volumes, surgical and medical complications, organ support needs, organ failure scores, and length of stay in intensive care and hospital. Blood tests will monitor albumin levels during surgery to maintain target concentrations. The total study duration per participant includes screening before surgery and follow-up for 28 days postoperatively.

CONDITIONS

Brief Title

Efficacy of Intraoperative Use of 20% Albumin Combined With Ringer Lactate Versus Ringer Lactate During Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy

Research Team

A

Arthur Moreau, Dr

J

Jérôme Lambert, Pr

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here